| scholarly article | Q13442814 |
| P2093 | author name string | Xuan Wang | |
| Christine M Eischen | |||
| Mary Ann Thompson | |||
| Shaoying Li | |||
| Mick D Edmonds | |||
| Shan Liang | |||
| Sara McClintock-Treep | |||
| P2860 | cites work | miRNA gene promoters are frequent targets of aberrant DNA methylation in human breast cancer | Q21133750 |
| Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters | Q24645192 | ||
| A microRNA polycistron as a potential human oncogene | Q27860720 | ||
| c-Myc-regulated microRNAs modulate E2F1 expression | Q27861046 | ||
| The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism | Q29547302 | ||
| Application of SELDI-TOF mass spectrometry for the identification of differentially expressed proteins in transformed follicular lymphoma. | Q33201992 | ||
| The genetics of the E2F family of transcription factors: shared functions and unique roles | Q34646667 | ||
| Chromosomal breakpoints and structural alterations of the c-myc locus differ in endemic and sporadic forms of Burkitt lymphoma | Q35603098 | ||
| miR-31 and its host gene lncRNA LOC554202 are regulated by promoter hypermethylation in triple-negative breast cancer | Q35818402 | ||
| Dysfunction of the TP53 tumor suppressor gene in lymphoid malignancies | Q35909637 | ||
| Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanisms | Q36869113 | ||
| MicroRNA-17~92 plays a causative role in lymphomagenesis by coordinating multiple oncogenic pathways | Q37166300 | ||
| B-cell malignancies in microRNA Eμ-miR-17~92 transgenic mice | Q37318047 | ||
| Genetic basis for p53 overexpression in human breast cancer | Q37528810 | ||
| Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma | Q37533656 | ||
| Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma | Q37636972 | ||
| miR-223 regulates cell growth and targets proto-oncogenes in mycosis fungoides/cutaneous T-cell lymphoma | Q37653005 | ||
| The breast cancer oncogene EMSY represses transcription of antimetastatic microRNA miR-31. | Q37706322 | ||
| The diverse role of miR-31 in regulating cancer associated phenotypes. | Q38133768 | ||
| MYC deregulation in lymphoid tumors: molecular mechanisms, clinical consequences and therapeutic implications | Q38246989 | ||
| Cytogenetic alterations affecting BCL6 are predominantly found in follicular lymphomas grade 3B with a diffuse large B-cell component | Q38781630 | ||
| Bortezomib induces apoptosis of endometrial cancer cells through microRNA-17-5p by targeting p21. | Q39146357 | ||
| Epigenetic repression of miR-31 disrupts androgen receptor homeostasis and contributes to prostate cancer progression | Q39227406 | ||
| Down-regulation of class II phosphoinositide 3-kinase alpha expression below a critical threshold induces apoptotic cell death. | Q39993130 | ||
| Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival and transformation from follicular lymphoma | Q41211534 | ||
| MicroRNA biogenesis is required for Myc-induced B-cell lymphoma development and survival | Q42036775 | ||
| Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone. | Q50495776 | ||
| Molecular characterization of 9p21 deletions shows a minimal common deleted region removing CDKN2A exon 1 and CDKN2B exon 2 in diffuse large B-cell lymphomas. | Q54585310 | ||
| Comparison of cytogenetic analysis, southern analysis, and polymerase chain reaction for the detection of t(14; 18) in follicular lymphoma | Q72180404 | ||
| Prognostic significance of Ki-67 nuclear proliferative antigen, bcl-2 protein, and p53 expression in follicular and diffuse large B-cell lymphoma | Q77455156 | ||
| Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma | Q80281110 | ||
| MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas | Q81418207 | ||
| MicroRNAs in cancer | Q86065522 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | follicular lymphoma | Q123251 |
| P304 | page(s) | 118-126 | |
| P577 | publication date | 2015-11-30 | |
| P1433 | published in | Human Pathology | Q15756731 |
| P1476 | title | miR-31 and miR-17-5p levels change during transformation of follicular lymphoma | |
| P478 | volume | 50 |
| Q57817341 | Abnormal microRNA expression in the course of hematological malignancies |
| Q38893973 | Function and regulation of microRNA-31 in development and disease. |
| Q90380099 | Integrative Analysis of MicroRNA and Gene Interactions for Revealing Candidate Signatures in Prostate Cancer |
| Q49478023 | MicroRNA-17-5p contributes to osteoarthritis progression by binding p62/SQSTM1. |
| Q57814100 | MicroRNAs as Biomarkers of B-cell Lymphoma |
| Q33670880 | Transformation of Follicular Lymphoma to a High-Grade B-Cell Lymphoma With MYC and BCL2 Translocations and Overlapping Features of Burkitt Lymphoma and Acute Lymphoblastic Leukemia: A Case Report and Literature Review |
Search more.